Literature DB >> 21436332

Guidelines in Emergency Medicine Network (GEMNet): guideline for the management of tricyclic antidepressant overdose.

Richard Body1, Tom Bartram, Fawad Azam, Kevin Mackway-Jones.   

Abstract

The Guidelines in Emergency Medicine Network (GEMNet) has been created to promote best medical practice in a range of conditions presenting to emergency departments (EDs) in the UK. This guideline presents a summary of the best available evidence to guide the management of adult patients who present to the ED following an overdose of tricyclic antidepressant agents (TCA). The document has been developed following discussion among emergency physicians to decide which topics would benefit from the development of clinical guidelines. The document is intended as a guideline for use in the ED by emergency physicians and is based on the review of the best existing evidence for the diagnostic tools and treatments used in this setting. The document is summarised as a clinical decision support guideline that has been presented as an easy to follow algorithm. The intention is for each guideline to be updated and reviewed as further evidence becomes available. The formal revision date has been set at 5 years from publication, although the guideline is subject to continuous informal review.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21436332     DOI: 10.1136/emj.2010.091553

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  10 in total

1.  Co-ingestion of tricyclic antidepressants with selective norepinephrine reuptake inhibitors: Overdose in the emergency department.

Authors:  Jatin Kaicker; Joanna Bostwick
Journal:  Can Fam Physician       Date:  2016-06       Impact factor: 3.275

2.  Rapid diagnosis and treatment of severe tricyclic antidepressant toxicity.

Authors:  Simon Clark; Jerry W Catt; Terrell Caffery
Journal:  BMJ Case Rep       Date:  2015-10-14

3.  Case report: successful lipid resuscitation in multi-drug overdose with predominant tricyclic antidepressant toxidrome.

Authors:  Martyn Harvey; Grant Cave
Journal:  Int J Emerg Med       Date:  2012-02-02

Review 4.  Fluid Stewardship of Maintenance Intravenous Fluids.

Authors:  John R Carr; W Anthony Hawkins; Andrea Sikora Newsome; Susan E Smith; Clemmons Amber B; Christopher M Bland; Trisha N Branan
Journal:  J Pharm Pract       Date:  2021-04-08

Review 5.  Extracorporeal treatment for tricyclic antidepressant poisoning: recommendations from the EXTRIP Workgroup.

Authors:  Christopher Yates; Tais Galvao; Kevin M Sowinski; Karine Mardini; Tudor Botnaru; Sophie Gosselin; Robert S Hoffman; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Semin Dial       Date:  2014-04-09       Impact factor: 3.455

6.  Amitriptyline-induced ventricular tachycardia: a case report.

Authors:  Khandker Mohammad Nurus Sabah; Abdul Wadud Chowdhury; Mohammad Shahidul Islam; Bishnu Pada Saha; Syed Rezwan Kabir; Shamima Kawser
Journal:  BMC Res Notes       Date:  2017-07-14

7.  Extracorporeal treatment in children with acute severe poisoning.

Authors:  Xiaomei Sun; Xiuying Chen; Jing Lu; Yuhong Tao; Lijuan Zhang; Liqun Dong
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

8.  Esmolol for intractable ventricular arrhythmias in major amitriptyline toxicity.

Authors:  Peter Garrett; Steven Klupfel
Journal:  BMJ Case Rep       Date:  2022-07-22

9.  Arterial blood gas analysis and the outcome of treatment in tricyclic antidepressants poisoned patients with benzodiazepine coingestion.

Authors:  Ahmad Yaraghi; Nastaran Eizadi-Mood; Maryam Katani; Shadi Farsaei; Mahrang Hedaiaty; Seyyed Mohammad Mahdy Mirhosseini; Elham Beheshtian; Ali Mohammad Sabzghabaee
Journal:  Anesthesiol Res Pract       Date:  2015-01-08

10.  Successful retrieval using ultrathin transnasal esophagogastroduodenoscopy of a significant amount of residual tricyclic antidepressant following serious toxicity: a case report.

Authors:  Masato Miyauchi; Makiko Hayashida; Hiroyuki Yokota
Journal:  Int J Emerg Med       Date:  2013-10-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.